Safety and Efficacy Iodofiltic Acid I 123 in the Treatment of Acute Coronary Syndrome
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label phase 2 study recruiting low, moderate, and high likelihood ACS
patients from approximately 60 centers. Patients will be imaged with iodofiltic acid I 123
for the detection of myocardial ischemia. Readers independent of the clinical study centers
will review results of imaging studies in a blinded fashion at an imaging core lab. The
resulting independent reading of the images will be compared against the truth standard for
ACS.